Active pharmaceutical ingredients · Gene therapies · Biotechnology
Kolon Life Science
A Kolon-affiliated biotech developing drug ingredients and gene therapies. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
Business categories Pharmaceuticals & Biotechnology · Biopharma & Life Sciences · primary
Other companies in the same category
- Pharmaceuticals & Biotechnology: Alnylam Pharmaceuticals · Regeneron Pharmaceuticals · Moderna · AbbVie · Lilly (Eli)
102940.KQ Updated Jul 11, 2026 2 AI consumers· 2 recurring
Annual return · 2026-10-08'21+93.8%'22-12.4%'23-17.4%'24-18.1%'25+192.6%YTD-78%
Money in ▸·
Kolon Life Science
▸ Money out·
Financials & Segments
- Segments · Active pharmaceutical ingredients · Bio and gene therapy
Revenue from
No refined links yet.
Pays to
No refined links yet.